Integrating ESR1m Testing and Novel Oral SERDS Into Multidisciplinary Workflows: Regional Guidance for HR+, HER2- Advanced Breast Cancer
Alabama Oncology is proud to recognize Dr. John Piede for his recent participation as expert faculty in an Answers in CME panel discussion, Integrating ESR1m Testing and Novel Oral SERDs Into Multidisciplinary Workflows: Regional Guidance for HR+, HER2- Advanced Breast Cancer. Dr. Piede joined nationally recognized breast cancer experts to share a community oncology perspective… read more »